These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease. Tan KCB, Cheung CL, Lee ACH, Lam JKY, Wong Y, Shiu SWM. Clin J Am Soc Nephrol; 2020 Mar 06; 15(3):359-366. PubMed ID: 32075807 [Abstract] [Full Text] [Related]
3. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Ihara K, Skupien J, Kobayashi H, Md Dom ZI, Wilson JM, O'Neil K, Badger HS, Bowsman LM, Satake E, Breyer MD, Duffin KL, Krolewski AS. Diabetes Care; 2020 Nov 06; 43(11):2760-2767. PubMed ID: 32887710 [Abstract] [Full Text] [Related]
6. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial). Schutte E, Lambers Heerspink HJ, Lutgers HL, Bakker SJ, Vart P, Wolffenbuttel BH, Umanath K, Lewis JB, de Zeeuw D, Gansevoort RT. Am J Kidney Dis; 2015 Sep 06; 66(3):450-8. PubMed ID: 25987260 [Abstract] [Full Text] [Related]
7. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study. Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, Tanaka K, Ueda T, Senba H, Torisu M, Minami H, Matsuura B, Hiasa Y, Miyake Y. Endocr J; 2017 Dec 28; 64(12):1131-1136. PubMed ID: 28855437 [Abstract] [Full Text] [Related]
8. Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes. Lee CH, Cheung CYY, Woo YC, Lui DTW, Yuen MMA, Fong CHY, Chow WS, Xu A, Lam KSL. Diabetologia; 2019 Jan 28; 62(1):169-177. PubMed ID: 30267180 [Abstract] [Full Text] [Related]
9. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study. Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ. Diabetes Care; 2018 Apr 28; 41(4):739-747. PubMed ID: 29367427 [Abstract] [Full Text] [Related]
10. Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes. Tan KCB, Cheung CL, Lee ACH, Lam JKY, Wong Y, Shiu SWM. Diabetes Metab Res Rev; 2019 Feb 28; 35(2):e3093. PubMed ID: 30378236 [Abstract] [Full Text] [Related]
16. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group. Diabetes Care; 2008 Jun 28; 31(6):1165-9. PubMed ID: 18346990 [Abstract] [Full Text] [Related]
17. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014. Kume S, Araki SI, Ugi S, Morino K, Koya D, Nishio Y, Haneda M, Kashiwagi A, Maegawa H. J Diabetes Investig; 2019 Jul 28; 10(4):1032-1040. PubMed ID: 30451386 [Abstract] [Full Text] [Related]
18. Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy? Shoji T, Kanda T, Nakamura H, Hayashi T, Okada N, Nakanishi I, Shimizu Y, Tsubakihara Y. Clin Nephrol; 1996 Jun 28; 45(6):367-71. PubMed ID: 8793227 [Abstract] [Full Text] [Related]
19. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes. Saulnier PJ, Dieter BP, Tanamas SK, McPherson SM, Wheelock KM, Knowler WC, Looker HC, Meek RL, Nelson RG, Tuttle KR. Am J Nephrol; 2017 Jun 28; 46(4):276-284. PubMed ID: 28934744 [Abstract] [Full Text] [Related]